Country: জার্মানি
ভাষা: ইংরেজি
সূত্র: HMA (Heads of Medicines Agencies)
marbofloxacin 20 mg
Krka d.d.
QJ01MA93
Solution for injection
marbofloxacin
Cattle, Pigs
2011-02-23
1.3.1 Marbofloxacin SPC, Labeling and Package Leaflet FR SmPCPIL013708/3 20.09.2010 – Updated: 10.02.2011 Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1.3.1 Marbofloxacin SPC, Labeling and Package Leaflet FR SmPCPIL013708/3 20.09.2010 – Updated: 10.02.2011 Page 2 of 6 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Quiflox 20 mg/ml solution for injection for cattle (calves) and pigs Marfloquin 20 mg/ml solution for injection for cattle (calves) and pigs Quiflox 20 mg/ml solution for injection for cattle (calves) and pigs (Czech Republic, Hungary, Latvia, Lithuania, Slovak Republic) Marfloquin 20 mg/ml solution for injection for cattle (calves) and pigs (Austria, Belgium, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Netherlands, Norway, Portugal, Spain, United Kingdom) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml of solution for injection contains: ACTIVE SUBSTANCE: Marbofloxacin 20 mg EXCIPIENTS: Metacresol 2 mg Disodium edetate 0.10 mg Monothioglycerol 0.50 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for injection. Clear, greenish yellow to brownish yellow solution. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle (calves). Pigs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES In pre-ruminant and ruminant calves: - treatment of respiratory infections caused by sensitive strains of _Pasteurella multocida_, _Mannheimia haemolytica_, and _Mycoplasma bovis_. In pigs: - treatment of respiratory infections caused by sensitive strains of সম্পূর্ণ নথি পড়ুন